new XtalPi, a SoftBank-backed Chinese unicorn that applies AI techniques for drug development, is planning to establish a research base in Hong Kong. The Shenzhen-based biotech firm is also setting up an investment fund called 42 Capital Partners, a senior executive told DealStreetAsia., 9h ago